Assessment of exoprotein concentration in a 50-mL culture of MH96. حسب Marion Schoof (11999106)

IP-10 treatment decreases ZIKV replication in low passage ZIKV infection of prostate stromal MSCs. حسب Jennifer L. Spencer Clinton (5234252)

IP-10 treatment decreases ZIKV replication in low passage ZIKV infection of prostate epithelial cells. حسب Jennifer L. Spencer Clinton (5234252)

While NA formation is substrate stiffness independent, maturation is influenced considerably by stiffness. حسب Kailas Shankar Honasoge (17108745)

Host population bottlenecks decrease microbiome diversity. حسب Michael Ørsted (5926028)

The mRNA expression of selected genes in cartilage cells after siRNA treatment were significantly decreased. حسب Fei Ye (339913)

Measurement of ATP production in HL-1 cells exposed for 12 or 72h to LG, NG, HG or IHG. حسب Patrick Mordel (17020879)

FTY720 decreased viability, proliferation, and motility and induced apoptosis in human hepatoblastoma cells. حسب Laura L. Stafman (6577184)

"…<p>(A) Following 24 hours of treatment with FTY720, the viability of HuH6 cells measured using the alamarBlue cell viability assay was significantly decreased (LD₅₀ = 8.4 μM, p ≤ 0.05). …"

E₅₀ values. حسب Junxia Zhou (14381598)

Predicting pattern diversity decreases as a function of and . حسب Selim Haj Ali (21222613)

"…(a) and (b): Average negative predictive value for and , respectively for and . …"

Minimum quorum sensing inhibitory concentrations (MQSICs), minimum inhibitory concentrations (MICs), and concentrations inhibiting 50% of violacein production (IC50s) of compounds... حسب Jean Paul Dzoyem (6424445)

الموضوعات:

Participants with virologic suppression or failure at week 24. حسب Tosi M. Mwakyandile (16408705)

الموضوعات:

Socio-demographic and clinical characteristics of HIV-infected treatment-naïve individuals initiating ART. حسب Tosi M. Mwakyandile (16408705)

الموضوعات:

Consolidated Standards of Reporting Trials flow diagram for participants in the trial. حسب Tosi M. Mwakyandile (16408705)

الموضوعات:

Changes in baseline CD4 count through week 12 and week 24 according to the linear regression model. حسب Tosi M. Mwakyandile (16408705)

الموضوعات:

Most frequently experienced adverse events among study participants by treatment arms from baseline through week 24. حسب Tosi M. Mwakyandile (16408705)

الموضوعات:

Cumulative incidence of mortality and loss to follow-up (LTF) among study participants by treatment arms from baseline through week 24. حسب Tosi M. Mwakyandile (16408705)

الموضوعات:

Cumulative incidence of morbidity, loss to follow-up (LTF) and mortality among study participants by treatment arms from baseline through week 24. حسب Tosi M. Mwakyandile (16408705)

الموضوعات:

Median changes in CD4 count, platelet activation, immune activation, and exhaustion markers from baseline through week 12 and week 24. حسب Tosi M. Mwakyandile (16408705)

الموضوعات:

The concentrations of VEGFA secreted from the vertebral endplate during organ culture (ng/L, n = 4, x ± s). حسب Jia-Wen Zhan (9028652)